To support growth of the international biopharmaceutical development sector, #Bioworkshops is pleased announce that we have become a Sponsor of #The Antibody Society.

The manufacturing of biologics over the years has evolved significantly, resulting in the development of new multimeric antibody classes, much different from the earlier versions.

As a new generation biological drug CDMO in Suzhou, Bioworkshops accepted an interview with JSBC.

In 2020, Bioworkshops continued to breakthrough and develop at a high speed. As a new CDMO, “Bioworkshops speed” has become recognized within the industry and acclaimed by our customers. In the past year, Bioworkshops exceeded its targets and achieved great results.

Bioworkshops has been audited by the Jiangsu Provincial Drug Administration, the regional authority of the China NMPA, and received a Drug Manufacturing License.

On September 26, 2020, Bioworkshops invited members of the New Drug Founders Club to a business Open Day.

During the Enterprise Open Day in September, SIP media visited Bioworkshops and Dr. Nick Kotlarski, COO of Bioworkshops spoke with them about how the company, as a new CDMO, set up in only one year and its plan for the future.

On September 11, 2020, Bioworkshops held our first Enterprise Open Day, attended by government leaders and industry experts from the pharmaceutical industry.

Bioworkshops and QuaCell Biotechnology,Co.,Ltd. (hereinafter referred to as ‘QuaCell’) jointly announce the strategic cooperation agreement to provide outstanding CHO-K1Q host cell platform and CDMO project services.

On 11 April , 2020, Bioworkshops marked its first birthday amidst the heightened healthcare precautions .